Literature DB >> 1881532

Functional role of brain CCK receptors.

G N Woodruff1, D R Hill, P Boden, R Pinnock, L Singh, J Hughes.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1881532     DOI： 10.1016/0143-4179(91)90082-t

Source DB:  PubMed          Journal:  Neuropeptides        ISSN： 0143-4179            Impact factor:   3.286


× No keyword cloud information.
  16 in total

1.  Conditioned preference for sweet stimuli in OLETF rat: effects of food deprivation.

Authors:  Bart C De Jonghe; Andras Hajnal; Mihai Covasa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-02-01       Impact factor: 3.619

2.  Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons.

Authors:  K K Miller; A Hoffer; K R Svoboda; C R Lupica
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

3.  Brief intermittent access to sucrose differentially modulates prepulse inhibition and acoustic startle response in obese CCK-1 receptor deficient rats.

Authors:  Bart C De Jonghe; Carmine Di Martino; Andras Hajnal; Mihai Covasa
Journal:  Brain Res       Date:  2005-08-02       Impact factor: 3.252

Review 4.  Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.

Authors:  G Debonnel
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

5.  Evaluation of a series of novel CCKB antagonists using a functional assay in the rat central nervous system.

Authors:  P R Boden; R D Pinnock; M C Pritchard; G N Woodruff
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

6.  Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.

Authors:  D J Dooley; I Klamt
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.

Authors:  S J Boyle; K W Tang; G N Woodruff; A T McKnight
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist.

Authors:  M Poncelet; M Arnone; M Heaulme; N Gonalons; C Gueudet; V Santucci; O Thurneyssen; P Keane; D Gully; G Le Fur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

9.  2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.

Authors:  I S Ebenezer; B A Baldwin
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

10.  Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats.

Authors:  Z B You; T M Tzschentke; E Brodin; R A Wise
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.